JOINT FILING AGREEMENT
EXHIBIT 10.09
Each of the undersigned hereby agrees and consents that the Schedule 13D/A filed herewith (the
“Schedule 13D/A”) by Cornerstone BioPharma Holdings, Ltd. is filed on behalf of each of them
pursuant to the authorization of the undersigned to make such filing and that such Schedule 13D/A
is filed jointly on behalf of each of them, pursuant to Sections 13(d) and 13(g) of the Securities
Exchange Act of 1934, as amended, and the rules promulgated thereunder, including Rule 13d-1(k)(1).
Each of the undersigned hereby agrees that such Schedule 13D/A is, and any further amendments to
the Schedule 13D/A will be, filed on behalf of each of the undersigned. Each of the persons is not
responsible for the completeness or accuracy of the information concerning the other persons making
this filing unless such person knows or has reason to believe that such information is inaccurate.
This agreement may be signed in counterparts. This agreement is
effective as of May 18, 2009.
Dated: May 18, 2009 |
CORNERSTONE BIOPHARMA HOLDINGS, LTD. |
|||
| /s/ Xxxxx X. Xxxxxxx | ||||
| Name: | Xxxxx X. Xxxxxxx | |||
| Title: | President and Chief Executive Officer | |||
| CAROLINA PHARMACEUTICALS LTD. |
||||
| /s/ Xxxxx X. Xxxxxxx | ||||
| Name: | Xxxxx X. Xxxxxxx | |||
| Title: | Chief Executive Officer | |||
| CAROLINA PHARMACEUTICALS HOLDINGS, LTD. |
||||
| /s/ Xxxxx X. Xxxxxxx | ||||
| Name: | Xxxxx X. Xxxxxxx | |||
| Title: | Chief Executive Officer | |||
| /s/ Xxxxx X. Xxxxxxx | ||||
| Xxxxx X. Xxxxxxx | ||||
